| ［1］ |
Szabó K, Erdei L, Bolla BS, et al. Factors shaping the composition of the cutaneous microbiota［J］. Br J Dermatol, 2017,176（2）:344⁃351. doi: 10.1111/bjd.14967.
|
| ［2］ |
Scholz CF, Kilian M. The natural history of cutaneous propionibacteria, and reclassification of selected species within the genus Propionibacterium to the proposed novel genera Acidipropionibacterium gen. nov., Cutibacterium gen. nov. and Pseudopropionibacterium gen. nov［J］. Int J Syst Evol Microbiol, 2016,66（11）:4422⁃4432. doi: 10.1099/ijsem.0.001367.
|
| ［3］ |
Barnard E, Shi B, Kang D, et al. The balance of metagenomic elements shapes the skin microbiome in acne and health［J］. Sci Rep, 2016,6:39491. doi: 10.1038/srep39491.
|
| ［4］ |
McDowell A, Barnard E, Nagy I, et al. An expanded multilocus sequence typing scheme for propionibacterium acnes: investigation of ′pathogenic′, ′commensal′ and antibiotic resistant strains［J/OL］. PLoS One, 2012,7（7）:e41480. doi: 10.1371/journal.pone.0041480.
|
| ［5］ |
Lomholt HB, Kilian M. Clonality and anatomic distribution on the skin of antibiotic resistant and sensitive Propionibacterium acnes［J］. Acta Derm Venereol, 2014,94（5）:534⁃538. doi: 10. 2340/00015555⁃1794.
|
| ［6］ |
Dagnelie MA, Khammari A, Dréno B, et al. Cutibacterium acnes molecular typing: time to standardize the method［J］. Clin Microbiol Infect, 2018,24（11）:1149⁃1155. doi: 10.1016/j.cmi. 2018.03.010.
|
| ［7］ |
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: M100［M］. 28th ed. Wayne, PA: Clinical and Laboratory Standards Institute, 2018. http://www.iacld.ir/DL/public/CLSI⁃2018⁃M100⁃S28.pdf.
|
| ［8］ |
Yu Y, Champer J, Garbán H, et al. Typing of Propionibacterium acnes: a review of methods and comparative analysis［J］. Br J Dermatol, 2015,172（5）:1204⁃1209. doi: 10.1111/bjd.13667.
|
| ［9］ |
McDowell A. Over a decade of recA and tly gene sequence typing of the skin bacterium Propionibacterium acnes: what have we learnt?［J］. Microorganisms, 2017,6（1）. pii:E1. doi: 10.3390/microorga nisms6010001.
|
| ［10］ |
Dréno B, Pécastaings S, Corvec S, et al. Cutibacterium acnes （Propionibacterium acnes） and acne vulgaris: a brief look at the latest updates［J］. J Eur Acad Dermatol Venereol, 2018,32 Suppl 2:5⁃14. doi: 10.1111/jdv.15043.
|
| ［11］ |
Fitz⁃Gibbon S, Tomida S, Chiu BH, et al. Propionibacterium acnes strain populations in the human skin microbiome associated with acne［J］. J Invest Dermatol, 2013,133（9）:2152⁃2160. doi: 10.1038/jid.2013.21.
|
| ［12］ |
Lomholt HB, Kilian M. Population genetic analysis of Propionibacterium acnes identifies a subpopulation and epidemic clones associated with acne［J/OL］. PLoS One, 2010,5（8）:e12277. doi: 10.1371/journal.pone.0012277.
|
| ［13］ |
McDowell A, Nagy I, Magyari M, et al. The opportunistic pathogen Propionibacterium acnes: insights into typing, human disease, clonal diversification and CAMP factor evolution［J/OL］. PLoS One, 2013,8（9）:e70897. doi: 10.1371/journal.pone.0070 897.
|
| ［14］ |
Kwon HH, Yoon JY, Park SY, et al. Analysis of distribution patterns of Propionibacterium acnes phylotypes and Peptostreptococcus species from acne lesions［J］. Br J Dermatol, 2013,169（5）:1152⁃1155. doi: 10.1111/bjd.12486.
|
| ［15］ |
Lomholt HB, CFP S, Brüggemann H, et al. A comparative study of Cutibacterium （Propionibacterium） acnes clones from acne patients and healthy controls［J］. Anaerobe, 2017,47:57⁃63. doi: 10.1016/j.anaerobe.2017.04.006.
|
| ［16］ |
Yu Y, Champer J, Agak GW, et al. Different Propionibacterium acnes phylotypes induce distinct immune responses and express unique surface and secreted proteomes［J］. J Invest Dermatol, 2016,136（11）:2221⁃2228. doi: 10.1016/j.jid.2016.06.615.
|
| ［17］ |
Jasson F, Nagy I, Knol AC, et al. Different strains of Propionibacterium acnes modulate differently the cutaneous innate immunity［J］. Exp Dermatol, 2013,22（9）:587⁃592. doi: 10.1111/exd.12206.
|
| ［18］ |
Johnson T, Kang D, Barnard E, et al. Strain⁃level differences in porphyrin production and regulation in Propionibacterium acnes elucidate disease associations［J］. mSphere, 2016,1（1）:e00023⁃15. doi: 10.1128/mSphere.00023⁃15.
|
| ［19］ |
Oyewole AO, Birch⁃Machin MA. Sebum, inflammasomes and the skin: current concepts and future perspective［J］. Exp Dermatol, 2015,24（9）:651⁃654. doi: 10.1111/exd.12774.
|
| ［20］ |
Shu M, Kuo S, Wang Y, et al. Porphyrin metabolisms in human skin commensal Propionibacterium acnes bacteria: potential application to monitor human radiation risk［J］. Curr Med Chem, 2013,20（4）:562⁃568. doi: 10.2174/0929867311320040007.
|
| ［21］ |
Melnik BC. Linking diet to acne metabolomics, inflammation, and comedogenesis: an update［J］. Clin Cosmet Investig Dermatol, 2015,8:371⁃388. doi: 10.2147/CCID.S69135.
|
| ［22］ |
Tomida S, Nguyen L, Chiu BH, et al. Pan⁃genome and comparative genome analyses of Propionibacterium acnes reveal its genomic diversity in the healthy and diseased human skin microbiome［J］. MBio, 2013,4（3）:e00003⁃e00013. doi: 10.1128/mBio.00003⁃13.
|
| ［23］ |
Nakase K, Sakuma Y, Nakaminami H, et al. Emergence of fluoroquinolone⁃resistant Propionibacterium acnes caused by amino acid substitutions of DNA gyrase but not DNA topoisomerase IV［J］. Anaerobe, 2016,42:166⁃171. doi: 10.1016/j.anaerobe.2016.10.012.
|
| ［24］ |
Nakase K, Hayashi N, Akiyama Y, et al. Antimicrobial susceptibility and phylogenetic analysis of Propionibacterium acnes isolated from acne patients in Japan between 2013 and 2015［J］. J Dermatol, 2017,44（11）:1248⁃1254. doi: 10.1111/1346⁃8138.13913.
|
| ［25］ |
Nakase K, Nakaminami H, Takenaka Y, et al. Relationship between the severity of acne vulgaris and antimicrobial resistance of bacteria isolated from acne lesions in a hospital in Japan［J］. J Med Microbiol, 2014,63（Pt 5）:721⁃728. doi: 10. 1099/jmm.0.067611⁃0.
|
| ［26］ |
Sadhasivam S, Sinha M, Saini S, et al. Heterogeneity and antibiotic resistance in Propionibacterium acnes isolates and its therapeutic implications: blurring the lines between commensal and pathogenic phylotypes［J］. Dermatol Ther, 2016,29（6）:451⁃454. doi: 10.1111/dth.12391.
|
| ［27］ |
Sardana K, Gupta T, Garg VK, et al. Antibiotic resistance to Propionobacterium acnes: worldwide scenario, diagnosis and management［J］. Expert Rev Anti Infect Ther, 2015,13（7）:883⁃896. doi: 10.1586/14787210.2015.1040765.
|
| ［28］ |
Oh J, Byrd AL, Deming C, et al. Biogeography and individuality shape function in the human skin metagenome［J］. Nature, 2014,514（7520）:59⁃64. doi: 10.1038/nature13786.
|
| ［29］ |
Dreno B, Martin R, Moyal D, et al. Skin microbiome and acne vulgaris: Staphylococcus, a new actor in acne［J］. Exp Dermatol, 2017,26（9）:798⁃803. doi: 10.1111/exd.13296.
|
| ［30］ |
Nakatsuji T, Chiang HI, Jiang SB, et al. The microbiome extends to subepidermal compartments of normal skin［J］. Nat Commun, 2013,4:1431. doi: 10.1038/ncomms2441.
|
| ［31］ |
Wang Y, Kuo S, Shu M, et al. Staphylococcus epidermidis in the human skin microbiome mediates fermentation to inhibit the growth of Propionibacterium acnes: implications of probiotics in acne vulgaris［J］. Appl Microbiol Biotechnol, 2014,98（1）:411⁃424. doi: 10.1007/s00253⁃013⁃5394⁃8.
|
| ［32］ |
Christensen GJ, Scholz CF, Enghild J, et al. Antagonism between Staphylococcus epidermidis and Propionibacterium acnes and its genomic basis［J］. BMC Genomics, 2016,17:152. doi: 10. 1186/s12864⁃016⁃2489⁃5.
|
| ［33］ |
Mottin V, Suyenaga ES. An approach on the potential use of probiotics in the treatment of skin conditions: acne and atopic dermatitis［J］. Int J Dermatol, 2018,57（12）:1425⁃1432. doi: 10.1111/ijd.13972.
|
| ［34］ |
Liu J, Yan R, Zhong Q, et al. The diversity and host interactions of Propionibacterium acnes bacteriophages on human skin［J］. ISME J, 2015,9（9）:2078⁃2093. doi: 10.1038/ismej.2015.47.
|
| ［35］ |
O′Neill AM, Gallo RL. Host⁃microbiome interactions and recent progress into understanding the biology of acne vulgaris［J］. Microbiome, 2018, 6（1）:177. doi: 10.1186/s40168⁃018⁃0558⁃5.
|
